Titan Biotech Limited engages in the manufacture and sale of biological products in India and internationally. It offers food ingredients, including hydrolyzed vegetable protein, yeast extract powder, calcium propionate powder, potassium sorbate, and calcium lactate; collagen and protein products, such as wheat hydrolysate protein, corn hydrolysate protein, bovine collagen peptide, collagen peptide, fish collage, undernatured chicken collagen type II, mucopolysaccharides, chicken protein isolate, soya protein isolate, and pea protein isolate; and brown rice protein, milk protein, protein hydrolysate, bovine cartilage extract, L-glutathione, cow colostrum powder, collagen peptides, whey protein, sodium caseinate, chondroitin sulphate, and hyaluronic acid. The company also provides coenzyme Q10, glucosamine KCL/HCL, methyl sulfonyl methane, chelated minerals, and peptone; OX bile extract, cholic acid, cerebroprotein hydrolysate, and iron protein succinylate; medicinal yeast and brewer ye
| Current Price | ₹457.80 |
|---|---|
| Market Cap | ₹1,892 Cr |
| Sector | Materials > Materials > Chemicals |
| Sub-Industry | Specialty Chemicals > 0 |
| P/E Ratio | 63.3 |
| Return on Equity | 17.84% |
| 52-Week Range | ₹3,303.10 – ₹4,605.00 |
| Beta (1Y) | -1.33 |
| Dividend Yield | 0.11% |
Titan Biotech Ltd is trading at ₹457.80, with a market capitalisation of ₹1,892 Cr.
Titan Biotech Ltd operates in the Materials > Materials > Chemicals space (Specialty Chemicals > 0).
Titan Biotech Ltd has a P/E of 63.3 and a return on equity of 17.84%.